The Globe and Mail reports in its Thursday, Oct. 24, edition that ahead of Exchange Income's Nov. 7 quarterly release, TD Cowen analyst Tim James trimmed his share target to $67 from $69 with an unchanged "buy" recommendation. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $65.61. Mr. James says in a note, "We believe an in-line quarter that provides evidence of accelerating organic growth in 2025 based on Window Solutions, three medevac contracts, Air Canada regional flying and international surveillance opportunities should be positive for the share price over the coming months." The Globe reported on Nov. 2, 2023, that Mr. James had reiterated his "buy" call for Exchange Income. The shares could then be had for $42.96. The Globe reported on Aug. 13, 2024, that ATB Capital Markets analyst Chris Murray had reaffirmed his "outperform" recommendation for Exchange Income. The shares could then be had for $46.75.